Rick Sullivan

Chief Financial Officer, Senseonics Holdings, Inc.

Search every verified Rick Sullivan interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Rick Sullivan, Chief Financial Officer at Senseonics Holdings, discussed the company's financial results and outlook during a March 3, 2025 earnings call. He reported fourth-quarter 2024 net revenue of $8.3 million, compared to $8 million in the prior year period, with US revenue of $6.2 million and revenue outside the US of $2.1 million. He also noted the company's revenue recognition process under its collaboration agreement with Ascensia, which involves revenue sharing based on contract duration and annual revenue levels. Sullivan provided guidance for full-year 2025, projecting global net revenue of approximately $34 to $38 million. He attributed this outlook to the ongoing transition of US patients to the Eversense 365 product following its fourth-quarter launch, as well as factors including the timeline for regulatory approval and commercial launch of Eversense 365 outside the United States, efforts to shift US reimbursement from Eversense E3 to Eversense 365, and plans related to specific initiatives. During the call, he also addressed questions about the early adoption of the 365-day sensor, stating that the company had recently expanded its focus from endocrinology to primary care, where it expects most patients to come from, and expressed encouragement with early signs from that expansion.